Reversing Age: New Trials on the Horizon
Kilder
- Nature: This method to reverse cellular ageing is about to be tested in humans - Nature
- Statnews: Gilead to buy cancer biotech Tubulis for more than $3 billion - statnews.com
- Statnews: Merck's experimental HIV prevention pill could be made for less than $5 a year, researchers say - statnews.com
- Fiercebiotech: E2 lands $80M series C for next-gen thrombectomy treatment - Fierce Biotech
- Bioworld: South Korea streamlines biosimilar review, clinical trials - BioWorld MedTech
- Bioworld: Gilead buying Tubulis and its ADCs in $5B takeover bid - BioWorld MedTech
- wikimedia: Photo by NIH Image Gallery from Bethesda, Maryland, USA / Wikimedia Commons / Public domain
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.